Clinical examinations by cSLO and OCT, and ocular histology showed that compared with the vehicle group (EAU + DMSO), mice treated with GHRH agonist (EAU + MR-409) developed more severe uveitis, while mice treated with GHRH antagonist (EAU + MIA-602) produced less uveitis (Fig. 6a, b and Supplementary Fig. 6a–c). This evidence concerns the gene GHRH and uveitis.